AARDEX Group

AARDEX Adherence M&S center used to differentiate between once- and twice-daily dosing in oral anticoagulation

Drug_Discovery
Compelling data presented at the 27th edition of JESFC, Paris, January 13, 2017

JAN-2017 : Compelling data presented at the 27th edition of JESFC, Paris, January 13, 2017.

Journées Européennes de la Société Française de Cardiologie 2017 (JESFC-2017)

Les anticoagulants oraux directs : des preuves d’aujourd’hui aux attentes de demain

Share This Post

You may also like...

Breaking News

Dose reduction’s role in tackling Pharma 2.0’s profitability problem

The economic model that has underpinned the development of drug products for decades is currently under siege. Faced on one side with mounting pressure from payers to address affordability issues, pharmaceutical companies are facing ever more stringent regulatory requirements alongside